Altafluor benox 0.25%-0.4% DRP 5ML
Ended Awarded
- Contract number
- SPE2DR26FCYW5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,014
Award facts
- Contract value 100% obligated
- $1,014.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,014.00 to DMS Pharmaceutical Group Inc. for Altafluor Benox 0.25%-0.4% ophthalmic drops (5mL) with an ultimate completion date of November 18, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. This delivery order was issued under the company's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025, with a ceiling value of $499,999,999.
The PPV-G GEN V contract positions DMS Pharmaceutical Group as a critical regional prime vendor contractor within the broader $30.3 billion acquisition strategy supporting Department of Defense military healthcare operations globally. Under this indefinite delivery vehicle, which runs through December 31, 2036 with a 30-month base period and three 30-month option periods, the DLA is authorized to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FCYW5?
SPE2DR26FCYW5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FCYW5 worth?
The government has obligated $1,014 on SPE2DR26FCYW5.
Is contract SPE2DR26FCYW5 an order under another contract?
Yes. SPE2DR26FCYW5 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYW5 competed?
The extent of competition for SPE2DR26FCYW5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award